Semaglutide and Follow-On Peptide Therapeutics: Balancing Innovation, Regulation, and Clinical Outcomes.

Teli B, Somani S, Arya V, Rajput PJ, Kahale P, Bharmal V, Shah S, Patel V, Ahuja A, Patange S.

Open source

DOI
10.7759/cureus.108999
Published
2026-05-16
Container
Cureus
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.7759/cureus.108999,
  title = {Semaglutide and Follow-On Peptide Therapeutics: Balancing Innovation, Regulation, and Clinical Outcomes.},
  author = {Teli B and  Somani S and  Arya V and  Rajput PJ and  Kahale P and  Bharmal V and  Shah S and  Patel V and  Ahuja A and  Patange S.},
  year = {2026},
  journal = {Cureus},
  doi = {10.7759/cureus.108999},
  url = {https://doi.org/10.7759/cureus.108999}
}

RIS

TY  - JOUR
TI  - Semaglutide and Follow-On Peptide Therapeutics: Balancing Innovation, Regulation, and Clinical Outcomes.
AU  - Teli B
AU  -  Somani S
AU  -  Arya V
AU  -  Rajput PJ
AU  -  Kahale P
AU  -  Bharmal V
AU  -  Shah S
AU  -  Patel V
AU  -  Ahuja A
AU  -  Patange S.
PY  - 2026
JO  - Cureus
DO  - 10.7759/cureus.108999
UR  - https://doi.org/10.7759/cureus.108999
ER  - 

APA

B, T., S, S., V, A., PJ, R., P, K., V, B., S, S., V, P., A, A., & S., P. (2026). Semaglutide and Follow-On Peptide Therapeutics: Balancing Innovation, Regulation, and Clinical Outcomes.. Cureus. https://doi.org/10.7759/cureus.108999

Source records